DD-03-171 is a PROTAC BTK degrader. DD-03-171 inhibits mantle cell lymphoma (MCL) cell proliferation (IC50 = 5.1 nM) and prolongs the survival of mice bearing a lymphoma PDX model by degrading BTK, IKFZ1, and IKFZ3. DD-03-171 also inhibits platelet function and thrombosis. (Pink: BTK ligand 9 (HY-168292), Black: linker (HY-28875), Blue: Thalidomide-NH-CH2-COOH (HY-131717))[1][2][3].
Molecular Weight:
991.14
Purity:
98.72
CAS Number:
[2366132-45-6]
Formula:
C55H62N10O8
Target:
Btk,NF-kappaB,PROTACs
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted